US 7429571
Therapeutic furopyrimidines and thienopyrimidines
granted A61KA61K31/675A61K31/7076
Quick answer
US patent 7429571 (Therapeutic furopyrimidines and thienopyrimidines) held by BioCryst Pharmaceuticals, Inc. expires Mon Sep 25 2028 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- BioCryst Pharmaceuticals, Inc.
- Grant date
- Tue Sep 30 2008 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Sep 25 2028 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 16
- CPC classes
- A61K, A61K31/675, A61K31/7076, A61K38/212, A61K38/2292